These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 21844075

  • 1. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G, REMEDIAL II Investigators.
    Circulation; 2011 Sep 13; 124(11):1260-9. PubMed ID: 21844075
    [Abstract] [Full Text] [Related]

  • 2. Renalguard system in high-risk patients for contrast-induced acute kidney injury.
    Briguori C.
    Minerva Cardioangiol; 2012 Jun 13; 60(3):291-7. PubMed ID: 22653043
    [Abstract] [Full Text] [Related]

  • 3. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C, Visconti G, Ricciardelli B, Condorelli G, REMEDIAL II Investigators.
    EuroIntervention; 2011 Apr 13; 6(9):1117-22, 7. PubMed ID: 21518686
    [Abstract] [Full Text] [Related]

  • 4. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
    Lee SW, Kim WJ, Kim YH, Park SW, Park DW, Yun SC, Lee JY, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Suh J, Cho YH, Lee NH, Cheong SS, Yoo SY, Lee BK, Lee SG, Hyon MS, Shin WY, Lee SW, Jang JS, Park SJ.
    Am J Cardiol; 2011 May 15; 107(10):1447-52. PubMed ID: 21420063
    [Abstract] [Full Text] [Related]

  • 5. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.
    Eur Rev Med Pharmacol Sci; 2013 Feb 15; 17 Suppl 1():13-21. PubMed ID: 23436661
    [Abstract] [Full Text] [Related]

  • 6. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.
    Am J Kidney Dis; 2009 Oct 15; 54(4):602-9. PubMed ID: 19535188
    [Abstract] [Full Text] [Related]

  • 7. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT InvestigatorsResearch Institute, Hospital do Coração, São Paulo SP, Brazil..
    Circulation; 2011 Sep 13; 124(11):1250-9. PubMed ID: 21859972
    [Abstract] [Full Text] [Related]

  • 8. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
    Torigoe K, Tamura A, Watanabe T, Kadota J.
    Int J Cardiol; 2013 Sep 01; 167(5):2200-3. PubMed ID: 22717305
    [Abstract] [Full Text] [Related]

  • 9. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
    Barbanti M, Gulino S, Capranzano P, Immè S, Sgroi C, Tamburino C, Ohno Y, Attizzani GF, Patanè M, Sicuso R, Pilato G, Di Landro A, Todaro D, Di Simone E, Picci A, Giannetto G, Costa G, Deste W, Giannazzo D, Grasso C, Capodanno D, Tamburino C.
    JACC Cardiovasc Interv; 2015 Oct 01; 8(12):1595-604. PubMed ID: 26386766
    [Abstract] [Full Text] [Related]

  • 10. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
    Briguori C, Visconti G, Donahue M, De Micco F, Focaccio A, Golia B, Signoriello G, Ciardiello C, Donnarumma E, Condorelli G.
    Am Heart J; 2016 Mar 01; 173():67-76. PubMed ID: 26920598
    [Abstract] [Full Text] [Related]

  • 11. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.
    Am Heart J; 2009 Mar 01; 157(3):576-83. PubMed ID: 19249432
    [Abstract] [Full Text] [Related]

  • 12. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
    Briguori C, D'Amore C, De Micco F, Signore N, Esposito G, Napolitano G, Focaccio A, REMEDIAL III Investigators.
    Catheter Cardiovasc Interv; 2020 Apr 01; 95(5):895-903. PubMed ID: 31282129
    [Abstract] [Full Text] [Related]

  • 13. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
    Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, Dua A, Short L, Kane K.
    Lancet; 2014 May 24; 383(9931):1814-23. PubMed ID: 24856027
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M, Cengiz H, Hoeltgen R, Wieczorek M, Boedeker RH, Scheibelhut C, Boening A.
    J Invasive Cardiol; 2013 Jun 24; 25(6):276-83. PubMed ID: 23735352
    [Abstract] [Full Text] [Related]

  • 15. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
    Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A.
    Circulation; 2007 Mar 13; 115(10):1211-7. PubMed ID: 17309916
    [Abstract] [Full Text] [Related]

  • 16. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E, Poh KK, Lu Q, Zhang JJ, Tan N, Hou XM, Ong HY, Azan A, Chen SL, Chen JY, Ali RM, Fang WY, Lau TW, Tan HC.
    Int J Cardiol; 2015 Dec 15; 201():237-42. PubMed ID: 26301645
    [Abstract] [Full Text] [Related]

  • 17. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
    Koc F, Ozdemir K, Kaya MG, Dogdu O, Vatankulu MA, Ayhan S, Erkorkmaz U, Sonmez O, Aygul MU, Kalay N, Kayrak M, Karabag T, Alihanoglu Y, Gunebakmaz O.
    Int J Cardiol; 2012 Mar 22; 155(3):418-23. PubMed ID: 21106264
    [Abstract] [Full Text] [Related]

  • 18. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
    Vasheghani-Farahani A, Sadigh G, Kassaian SE, Khatami SM, Fotouhi A, Razavi SA, Mansournia MA, Yamini-Sharif A, Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Borumand MA, Esfehani FA, Darabian S.
    Am J Kidney Dis; 2009 Oct 22; 54(4):610-8. PubMed ID: 19619921
    [Abstract] [Full Text] [Related]

  • 19. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W, Fu XH, Gu XS, Wang YB, Wang XC, Li W, Jiang YF, Hao GZ, Fan WZ, Xue L.
    Chin Med J (Engl); 2012 Oct 22; 125(19):3368-72. PubMed ID: 23044290
    [Abstract] [Full Text] [Related]

  • 20. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M.
    Am J Cardiol; 2007 Sep 01; 100(5):781-6. PubMed ID: 17719320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.